Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pain medication tapering for chronic low back pain patients
2024-516647-79-00Phase 4Authorised
- Sponsor
- Vrije Universiteit Brussel
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of Suboxone, pregabalin + celecoxib, oxycodone and clonidine in post-laminectomy syndrome (PLS) and chronic low back pain (CLBP) (3 arms), sponsored by Vrije Universiteit Brussel. Primary endpoint: Change in Oswestry Disability Index (ODI). Planned start Oct 2024; status: authorised.
02
Drugs
Suboxonepregabalin + celecoxiboxycodoneclonidine
03
Conditions
post-laminectomy syndrome (PLS)chronic low back pain (CLBP)
Beyond the preview
Go deeper on 2024-516647-79-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516647-79-00.